Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Liu
Georgetown University Hospital Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Peter Maccallum
East Melbourne, Victoria, Australia
- University of Southern California-Norris
Los Angeles, California, United States
- Stanford School of Medicine
Stanford, California, United States
- Georgetown Medical Center
Washington D.C., District of Columbia, United States
- University of Chicago
Chicago, Illinois, United States
- Walter Reed National Military Cancer Center
Bethesda, Maryland, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center (vicc)
Nashville, Tennessee, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 31 Jan 2017
- Completion
- 31 Jan 2017
- Last update posted
- 12 Jan 2023
- Registered enrollment
- 30
- Registry id
- NCT02449681
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.